Nuclear distribution of human DNA topoisomerase IIβ: A nuclear targeting signal resides in the 116-residue C-terminal tail

Experimental Cell Research

Volumn 243, Issue 2, 1998, Pages 232-240

  Cowell, Ian G ^a   Willmore, Elaine ^a   Chalton, David ^a   Marsh, Katherine L ^a   Jazrawi, Elen ^b   Fisher, L Mark ^b   Austin, Caroline A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Immunocytochemistry; Nuclear localization; Nucleoli; Nucleus; Topoisomerase II

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING);

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELLULAR DISTRIBUTION; ENZYME ASSAY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0032531260     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4150     Document Type: Article

References (36)

1. Wang J. C. DNA topoisomerases. Annu. Rev. Biochem. 65:1996;635-692.
2. Drake F. H., Hofmann G. A., Bartus H. F., Mattern M. R., Crooke S. T., Mirabelli C. K. Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry (USA). 28:1989;8154-8160.
3. Drake F. H., Zimmerman J. P., McCabe F. L., Bartus H. F., Per S. R., Sullivan D. M., Ross W. E., Mattern M. R., Johnson R. K., Crooke S. T. Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells: Evidence for two forms of the enzyme. J. Biol. Chem. 262:1987;16739-16747.
4. Chung T. D. Y., Drake F. H., Tan K. B., Per S. R., Crooke S. T., Mirabelli C. K. Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isoenzymes. Proc. Natl. Acad. Sci USA. 86:1989;9431-9435.
5. Tsai Pflugfelder M., Liu L. F., Liu A. A., Tewey K. M., Whang Peng J., Knutsen T., Huebner K., Croce C. M., Wang J. C. Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22. Proc. Natl. Acad. Sci USA. 85:1988;7177-7181.
6. Austin C. A., Fisher L. M. Isolation and characterization of a human cDNA clone encoding a novel DNA topoisomerase II homologue from HeLa cells. FEBS Lett. 266:1990;115-117.
7. Austin C. A., Sng J.-H., Patel S., Fisher L. M. Novel HeLa topoisomerase II is the IIβ isoform: Complete coding sequence and homology with other type II topoisomerases. Biochim. Biophys. Acta. 1172:1993;283-291.
8. Davies S. L., Jenkins J. R., Hickson I. D. Human cells express two differentially spliced forms of topoisomerase II β mRNA. Nucleic Acids Res. 21:1993;3719-3723.
9. Jenkins J. R., Ayton P., Jones T., Davies S. L., Simmons D. L., Harris A. L., Sheer D., Hickson I. D. Isolation of cDNA clones encoding the beta isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24. Nucleic Acids Res. 20:1992;5587-5592.
10. Austin C. A., Marsh K. L., Wasserman R. A., Willmore E., Sayer P. J., Wang J. C., Fisher L. M. Expression, domain structure, and enzymatic properties of an active recombinant human DNA topoisomerase IIβ J. Biol. Chem. 270:1995;15739-15746.
11. Adachi, N. Kobayashi, M. Koyama, H. 1997, The Eighth Conference on DNA topoisomerases in Therapy, 28, 28.
12. Dereuddre S., Delaporte C., JacqueminSablon A. Role of topoisomerase IIβ in the resistance of 9-OH-ellipticine-resistant Chinese hamster fibroblasts to topoisomerase II inhibitors. Cancer Res. 57:1997;4301-4308.
13. Austin C. A., Marsh K. L. Eukaryotic DNA topoisomerase IIβ BioEssays. 20:1998;215-226.
14. Caron P. R., Watt P., Wang J. C. The C-terminal domain ofSaccharomyces cerevisiae. Mol. Cell. Biol. 14:1994;3197-3207.
15. Crenshaw D. G., Hsieh T. S. Function of the hydrophilic carboxyl terminus of type II DNA topoisomerase from Drosophila melanogaster. II. In vivo studies. J. Biol. Chem. 268:1993;21335-21343.
16. Adachi N., Miyaike M., Kato S., Kanamaru R., Koyama H., Kikuchi A. Cellular distribution of mammalian DNA topoisomerase II is determined by its catalytically dispensable C-terminal domain. Nucleic Acids Res. 25:1997;3135-3142.
17. Chaly N., Chen X., Dentry J., Brown D. L. Organization of DNA topoisomerase II isotypes during the cell cycle of human lymphocytes and HeLa cells. Chromosome Res. 4:1996;457-466.
18. Meyer K. N., Kjeldsen E., Straub T., Knudsen B. R., Hickson I. D., Kikuchi A., Kreipe H., Boege F. Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities. J. Cell Biol. 136:1997;775-788.
19. Taagepera S., Rao P. N., Drake F. H., Gorbsky G. J. DNA topoisomerase IIα is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2. Proc. Natl. Acad. Sci USA. 90:1993;8407-8411.
20. Chaly N., Brown D. L. Is DNA topoisomerase IIβ a nucleolar protein. J. Cell. Biochem. 63:1996;162-173.
21. Negri C., Chiesa R., Cerino A., Bestagno M., Sala C., Zini N., Maraldi N. M., Ricotti G. G. C. B. A. Monoclonal antibodies to human DNA topoisomerase I and the two isoforms of DNA topoisomerase II: 170- and 180-kDa isozymes. Exp. Cell Res. 200:1992;452-459.
22. Zini N., Martelli A. M., Sabatelli P., Santi S., Negri C., Ricotti G. C. B. A., Maraldi N. M. The 180-kDa isoform of topoisomerase II is localized in the nucleolus and belongs to the structural elements of the nucleolar remnant. Exp. Cell Res. 200:1992;460-466.
23. Maeda Y., Hisatake K., Kondo T., Hanada K., Song C. Z., Nishimura T., Muramatsu M. Mouse ribosomal-RNA gene-transcription factor mUBF requires both HMG-box1 and an acidic tail for nucleolar accumulation - molecular analysis of the nucleolar targeting mechanism. EMBO J. 11:1992;3695-3704.
24. Petrov P., Drake F. H., Loranger A., Huang W., Hancock R. Localization of DNA topoisomerase II in Chinese hamster fibroblasts by confocal and electron microscopy. Exp. Cell Res. 204:1993;73-81.
25. Rattner J. B., Hendzel M. J., Furbee C. S., Muller M. T., BazettJones D. P. Topoisomerase II α is associated with the mammalian centromere in a cell cycle- and species-specific manner and is required for proper centromere/kinetochore structure. J. Cell. Biol. 134:1996;1097-1107.
26. Mirski S. E. L., Cole S. P. C. Cytoplasmic localization of a mutant M(r) 160,000 topoisomerase IIα is associated with the loss of putative bipartite nuclear localization signals in a drug-resistant human lung cancer cell line. Cancer Res. 55:1995;2129-2134.
27. Harker W. G., Slade D. L., Parr R. L., Holguin M. H. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase IIα messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone. Cancer Res. 55:1995;4962-4971.
28. Dingwall C., Laskey R. A. Nuclear targeting sequences - A consensus? Trends Biochem. Sci. 16:1991;478-481.
29. Robbins J., Dilworth S. M., Laskey R. A., Dingwall C. Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: Identification of a class of bipartite nuclear targeting sequence. Cell. 64:1991;615-623.
30. Harker W. G., Slade D. L., Parr R. L., Feldhoff P. W., Sullivan D. M., Holguin M. H. Alterations in the topoisomerase IIα gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase IIβ enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line. Cancer Res. 55:1995;1707-1716.
31. Wessel I., Jensen P. B., Falck J., Mirski S. E. L., Cole S. P. C., Sehested M. Loss of amino acids (1490)Lys-Ser-Lys(1492) in the COOH-terminal region of topoisomerase IIα in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization. Cancer Res. 57:1997;4451-4454.
32. Yu Q., Mirski S. E. L., Sparks K. E., Cole S. P. C. Two COOH-terminal truncated cytoplasmic forms of topoisomerase IIα in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicing. Biochemistry. 36:1997;5868-5877.
33. Mirski S. E., Gerlach J. H., Cummings H. J., Zirngibl R., Greer P. A., Cole S. P. Bipartite nuclear localization signals in the C terminus of human topoisomerase IIα Exp. Cell Res. 237:1997;452-455.
34. Wells N. J., Addison C. M., Fry A. M., Ganapathi R., Hickson I. D. Serine 1524 is a major site of phosphorylation on human topoisomerase IIα protein in vivo and is a substrate for casein kinase II in vitro. J. Biol. Chem. 269:1994;29746-29751.
35. Wells N. J., Hickson I. D. Human topoisomerase IIα is phosphorylated in a cell-cycle phase-dependent manner by a proline-directed kinase. Eur. J. Biochem. 231:1995;491-497.
36. Jans D. A., Moll T., Nasmyth K., Jans P. Cyclin-dependent kinase site-regulated signal-dependent nuclear localization of the SWI5 yeast transcription factor in mammalian cells. J. Biol. Chem. 270:1995;17064-17067.